Life Insurance Q4 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Life Insurance management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Life Insurance management said on order book — free account, 30 seconds.
Capex plans
Track Life Insurance — get its next earnings analysis in your feed
Margin guidance
Order book
How does Life Insurance rank vs peers in Insurance?
Pro featureHow does Life Insurance rank in Insurance?
Compare Life Insurance against every Insurance company (Q4 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Life Insurance's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Insurance this season
- Niva Bupa Health (Q2 FY26)
October saw over 50% growth in retail sales, driven by GST reduction from 18% to 0%, enhancing affordability and demand. Key concall takeaways from Niva Bupa…
- Star Health Insu (Q2 FY26)
Fresh business growth robust, with about 50% growth in new policies noted in October. Key concall takeaways from Star Health & Allied Insurance Company Ltd's…
- Medi Assist Ser. (Q3 FY26)
Expansion of technology-led revenue streams, especially from SaaS products like MAtrix and AI-driven solutions such as MAven Guard, with tech revenues growing…
- Niva Bupa Health (Q1 FY27)
Group portfolio growth remains selective, focusing on profitable segments like SMEs growing over 50% (Page 6). Key concall takeaways from Niva Bupa Health…